Dr. Berard received her PhD in Medical Microbiology in 2015 through the University of Manitoba, where she studied the differences in proteomic expression in viral infections, performing a systems biology approach to study host-pathogenic interactions. During her post-doctoral work, Dr. Berard studied mucosal biology in the context of HIV infection to determine mechanisms of pathogenesis and increased acquisition using similar systems biology approaches, SIV macaque models, co-culture, and vaginal epithelial barrier models. As a Research Associate, she is studying how the microbiome affects female reproductive health using multi-omic approaches including metaproteomics, metabolomics, transcriptomics, and flow cytometry, as well as multiple experimental bacterial co-culture assays to test mechanisms of barrier dysfunction. She is currently co-leading the THRIVE BV study (“The Study of Host-bacterial Relationships and Immune function in different Vaginal Environments”), to prospectively investigate the kinetics and specific host, immune, and microbiome factors that lead to recurrent bacterial vaginosis (BV) in women.